重症児のモデルベースの精度用量投与の実施を評価する見通しの可行性研究
Izgi Bayraktar1, Merve Kaşıkcı2, Zuhal Benek1
1Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye.
Frontiers in pharmacology
|February 19, 2026
まとめ
モデル情報精度投与 (MIPD) は,重症児の抗生物質治療の最適化において有望であることが示されていますが,臨床上の利点を確認し,小児集中治療における実施を精密にするためにさらなる試験が必要です.
科学分野:
- 小児重症治療薬は,小児重症治療薬として使用されています.
- ファルマコキネティクスとファルマコダイナミクス
- 臨床薬理学 臨床薬理学とは
背景:
- 最適な抗生物質曝露は,生理学的変動性のために,重症児では困難です.
- 従来の投与は,バンコマイシンやアミカシンなどの狭い治療指数を持つ抗生物質の治療目標を達成するのにしばしば失敗する.
研究 の 目的:
- 小児重症病棟におけるモデル情報精度投与 (MIPD) の実現可能性と方法論的パフォーマンスを評価する.
- 重症児におけるバンコマイシンとアミカシンのMIPDガイドドージングと標準ケア (SoC) を比較する.
主な方法:
- 比較アームによる展望的,実用的な可行性研究.
- MIPDまたはSoCで管理されたバンコマイシンまたはアミカシンを投与している小児患者の観察分析.
- 主要アウトカム:予測の正確性とモデルフィット;次要アウトカム:用量最適化,炎症マーカー,腎臓安全性,治療期間,死亡率.
主要な成果:
- モデルフィットでは,MIPDとバンコマイシンではわずかな改善が見られたが,SoC群では変わらない.
- 臨床的アウトカムはグループによって類似していましたが,MIPDグループは,CRPとプロカルシトニンの減少が数値的に大きく,しかし無意味でした.
- 炎症マーカーのベースライン不均衡は,臨床結果の解釈を混乱させた.
結論:
- MIPDは,小児集中治療における抗生物質曝露を最適化するための潜在的に価値のあるアプローチです.
- 臨床的効果を確認し,この集団におけるMIPDの実施を最適化するために,さらなる多センター試験が必要である.
関連する概念動画
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
24
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
24
01:29Drug Dosing: Infants and Children
344
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
289
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
273
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
273
01:26Pharmacokinetic Models: Comparison and Selection Criterion
392
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
392
01:28Dosage Regimens: Designs and Approaches
350
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
350